source
- FDA approves Johnson & Johnson's Ottava robotic system for multiple soft-tissue surgeriesFDA cleared Johnson & Johnson's Ottava robotic surgical system, marking its entry into the market. The clearance covers a range of soft-tissue procedures such as gastric bypass, gastrectomy, chole…
- Roche stresses careful AI token use and pauses drug from Carmot acquisitionRoche's CEO Thomas Schinecker said the company is adopting a thoughtful approach to how it employs AI tokens, emphasizing responsible use. He noted that AI tools have already helped increase the n…